Showing results 21 to 40 of 43
< previous
next >
| Issue Date | Title | Author(s) |
| 2013 | Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choices | Singh, J; Longworth, L; Baine, A; Lord, J; Orr, S; Buxton, M |
| 2013 | Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choices | Singh, J; Longworth, L; Baine, A; Lord, J; Orr, S; Buxton, M |
| 2016 | The impact on health-related quality of life of caregiving within the household for people with arthritis | Garrett, Zoe Tara |
| 2012 | Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development | Claxton, K; Palmer, S; Longworth, L; Bojke, L; Griffin, S; McKenna, C; Soares, M; Spackman, E; Youn, J |
| 2015 | Mapping Functions in Health-Related Quality of Life: Mapping From Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L. | Young, TA; Mukuria, C; Rowen, D; Brazier, JE; Longworth, L |
| 2015 | The maps reporting statement for studies mapping onto generic preference-based outcome measures. | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2015 | The MAPS reporting statement for studies mapping onto generic preference-based outcome measures: Explanation and elaboration | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Froud, R; Gray, A |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 2015 | Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement | Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A |
| 1-Feb-2014 | Preparatory study for the Re-valuation of the EQ-5D tariff | Mulhern, B; Bansback, N; Brazier, J; Buckingham, K; Cairns, J; Devlin, N; Dolan, P; Hole, A; Kavetsos, G; Longworth, L; Rowen, D; Tsuchiya, A |
| 2016 | Proceedings of patient reported outcome measure’s (PROMs) conference Sheffield 2016: Advances in patient reported outcomes research | Croudace, T; Brazier, J; Gutacker, N; Street, A; Robotham, D; Waterman, S; Rose, D; Satkunanathan, S; Wykes, T; Nasr, N; Enderby, P; Carlton, J; Rowen, D; Elliott, J; Brazier, J; Stevens, K; Basarir, H; Labeit, A; Murphy, M; Hollinghurst, S; Salisbury, C; Marley, D; Wilson, J; Barrat, A; Roy, B; Rombach, I; Burke, Ó; Jenkinson, C; Gray, A; Rivero-Arias, O; Porter, I; Gangannagaripalli, J; Bramwell, C; Valderas, JM; Holch, P; Davidson, S; Routledge, J; Henry, A; Franks, K; Gilbert, A; Absolom, K; Velikova, G; Porter, I; Valderas, JM; Boehnke, JR; Trigg, A; Howells, R; Singh, J; Pokhrel, S; Longworth, L; Potter, C; Hunter, C; Kelly, L; Gibbons, E; Forder, J; Coulter, A; Fitzpatrick, R; Peters, M |
| 2014 | Reforming the cancer drug fund focus on drugs that might be shown to be cost effective | Buxton, M; Longworth, L; Raftery, J; Sculpher, M; Towse, A |
| 2012 | A review of generic preference-based measures of health-related quality of life in visual disorders | Tosh, J; Brazier, J; Evans, P; Longworth, L |
| 9-Nov-2021 | Use of [<sup>177</sup>Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study | Glover, M; Caplin, M; Leeuwenkamp, OR; Longworth, L |
| 2014 | Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey | Longworth, L; Yang, Y; Young, T; Mulhern, B; Hernandez, M; Mukuria, C; Rowen, D; Tosh, J; Tsuchiya, A; Evans, P; Keetharuth, A; Brazier, J |
| 2014 | Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: systematic review, statistical modelling and survey. | Longworth, L; Yang, Y; Young, T; Hernandez Alva, M; Mukuria, C; Rowen, D; Tosh, J; Tsuchiya, A; Evans, P; Keetharuth, A; Brazier, J |
